There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ginkgo Bioworks Holdings (DNA – Research Report), Roche Holding AG (RHHVF – Research Report) and Ramsay Health Care (RMSYF – Research Report) with bullish sentiments.
Roche Holding AG (RHHVF)
In a report released today, Luisa Hector from Berenberg Bank maintained a Buy rating on Roche Holding AG, with a price target of CHF320.00. The company’s shares closed last Tuesday at $294.78.
According to TipRanks.com, Hector is ranked #2011 out of 8527 analysts.
The word on The Street in general, suggests a Hold analyst consensus rating for Roche Holding AG with a $343.69 average price target, representing a 17.3% upside. In a report issued on August 24, Citi also maintained a Buy rating on the stock with a CHF350.00 price target.
Ramsay Health Care (RMSYF)
In a report issued on August 24, David Low from J.P. Morgan maintained a Buy rating on Ramsay Health Care, with a price target of A$60.00. The company’s shares closed last Friday at $36.55, close to its 52-week low of $34.50.
According to TipRanks.com, Low is a 1-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Ramsay Health Care with a $35.50 average price target, representing a -2.9% downside. In a report issued on August 25, Morgans also maintained a Buy rating on the stock with a A$66.40 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on DNA:
- Ginkgo Bioworks, ILRI enter MoU to collaborate on pandemic surveillance work
- Ginkgo Bioworks files to sell 5.28M shares of Class A common stock for holders
- Cathie Wood Pursues Innovation in Smaller Stocks
- Cathie Wood’s ARK Investment bought 203K shares of Ginkgo Bioworks today
- Cathie Wood’s ARK Investment bought 297.5K shares of Ginkgo Bioworks today
